Theralase Technologies Inc.
TLTFF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $49 | $47 | $46 | $62 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $49 | $48 | $46 | $62 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 27.3% | 141% | -77.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 56.8% | 54% | 14.6% | 64.1% |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | -336.7% | -403.1% | -1,536.5% | -205.7% |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -361.9% | -433.2% | -1,613.4% | -223.7% |
| EPS Diluted | -0.004 | -0.004 | -0.006 | -0.004 |
| % Growth | -5.3% | 36.7% | -57.9% | – |
| Operating Cash Flow | -$1 | -$1 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$1 | -$0 | -$0 |